John Blackwood - VP Biology - Samsara Therapeutics

“Prismea played a crucial role in our project, overseeing the development of a machine learning algorithm to identify autophagy inducers using image-based data. Their expertise in project management, technical guidance, and setting up infrastructure like AWS ensured our data processing pipelines ran efficiently.

What stood out most was their ability to communicate clearly, adapt to challenges, and focus on practical solutions that kept the project moving forward. Their support with version control and code management allowed our team to concentrate on the core research without being bogged down by operational complexities.

Working with Prismea was a great experience, and I’d highly recommend them to any team looking for a pragmatic, knowledgeable, and reliable partner.”

Anthony Underwood - Head of Bioinformatics - Broken String Biosciences

“Working with Prismea had a significant impact on our bioinformatics team's cloud DevOps. Although we had a solid foundation in cloud technologies, we needed expert insights into cloud DevOps and an understanding of the unique challenges in biotech. Mark's scientific background and pragmatic approach made a real difference. His strategic recommendations provided us with a clear path forward without unnecessary complexity. The collaboration was a true two-way partnership, and the high-level guidance we received has already led to meaningful improvements. Prismea truly understands the intersection of science and software engineering, making them an invaluable partner for any biotech company navigating cloud solutions.”

Sarah De Val - Associate Professor - University of Oxford

“Our lab lacked in-house bioinformatics expertise, which became a major hurdle when conducting a single-cell RNA sequencing experiment. We reached out to Mark, and his expertise proved invaluable. He not only helped us design the experiment and ensure it was statistically sound but also provided quality control and analysis of the data, allowing us to draw meaningful conclusions.

Mark’s support was instrumental in securing funding, as the data he helped generate strengthened our grant application, which was approved without issue. His contributions have also been included in a manuscript currently under review for publication.

Beyond delivering high-quality analysis, Mark played a key role in building our internal capabilities. Thanks to his guidance, one of our team members has now become proficient in bioinformatics, and we’ve since expanded our team to include a dedicated bioinformatician.

We highly recommend Mark to any research group needing bioinformatics expertise—his knowledge, professionalism, and collaborative approach make all the difference.”

Graham Speight - EVP R&D - Oxford Gene Technology

“"We didn't come into the AWS Health Check with any major concerns—our setup was relatively new, and costs were low. But as we prepare to scale from a handful of customer instances to hundreds, we wanted reassurance that everything was secure, efficient, and future-proof.

The assessment was extremely worthwhile. The report was clear, concise, and actionable—exactly what you want when juggling multiple priorities. We were particularly surprised by the cost-saving opportunities it uncovered, even at this early stage. It also gave us confidence that we’re fully aligned on GDPR, data protection, and infrastructure best practices.

One of the biggest benefits was identifying small vulnerabilities that could have become big problems down the line. The recommendations around account management and transitioning AWS responsibilities from our R&D team to a commercial environment were spot on.

Mark, who led the assessment, was knowledgeable, professional, and a pleasure to work with. He helped us think through not just today’s setup but the challenges we’re likely to face as we grow.

In terms of ROI, the potential savings alone more than justify the cost. I’d highly recommend doing an AWS Health Check proactively—even if everything seems fine. For us, it could become an annual ‘system MOT’ and a key part of how we reassure both ourselves and our customers that we’re building on solid ground.

Tom Congdon - CEO - CryoLogyx

“At CryoLogyx, maintaining quality, consistency, and traceability in our lab processes is critical. Prismea’s Sample Safe has been a game-changer, allowing us to centralize our sample tracking, inventory management, SOPs, and experiment data in one digital space.

As a growing biotech startup, flexibility is key for us—we appreciated that Prismea offered a trial-based approach without rigid contracts, making adoption seamless. Beyond inventory management, Sample Safe has also become our go-to digital lab notebook, streamlining data storage and experiment tracking.

The team at Prismea has been highly responsive to our needs, even accommodating unique feature requests. Their commitment to continuous improvement reassures us that we’ve chosen the right partner for our lab operations.”

Matt Brown - former CEO - Quorbit

“When my previous company, Quorbit, needed to obtain ISO 27001 certification to onboard large enterprise clients like Costa Coffee and Nike, Prismea made what could have been an overwhelming process clear and manageable. Their collaborative approach—with ready-to-use templates and a shared Confluence workspace—helped us efficiently build our information security management system. Despite some delays on our side, Prismea kept us on track, and we completed our preparation in around 2-3 months.

While we didn’t complete the final audit before Quorbit was acquired, the work we did with Prismea gave our acquirer confidence in our compliance and operational maturity. The certification process also strengthened our fundraising efforts and positioned us as a robust, security-conscious business. I’d absolutely recommend Prismea to any company looking to streamline their compliance journey and build investor and client trust."

Jolyon Holdstock - Director of Computational Biology - OGT

“As we started moving more of our software into the cloud, we knew AWS had a lot to offer—but we also knew we weren’t using it to its full potential. We’d used a contractor to set up the initial infrastructure but wanted an independent second opinion to make sure we were heading in the right direction.

The AWS Health Check gave us exactly that. It was thorough, insightful, and clearly grounded in real-world experience. We got practical recommendations around cost savings—such as using reserved instances and cleaning up storage—as well as some eye-openers on security and compliance, especially around permissions and underused AWS tools.

It didn’t significantly change our long-term roadmap, but it has helped shape our budget planning. One interesting takeaway was the idea of moving from Java to a leaner, more maintainable React-based setup—something we’re now seriously considering.

If you’re early in your cloud journey, I’d highly recommend doing a Health Check. It’s a smart way to catch issues before they become problems and to get an experienced, external perspective on where you stand. Even before we implemented any of the recommendations, it was already a valuable investment.

Sophie Payne - BHF Post-doctoral Scientist - University of Oxford

“As a wet lab researcher new to single-cell sequencing, the guidance and expertise provided by the Prismea team – especially Mark - was of great value to this project. Their unbiased, mathematical approach ensured that our data was processed and analysed correctly, and met the highest industry and publishing standards.

Prismea came highly recommended, and from the start they helped refine our experimental design, ensuring data quality and statistical power. This deep knowledge ensured that valuable time and British Heart Foundation funding was not wasted on unusable data.

Working with Prismea was a fantastic experience. Their ability to bridge the gap between wet lab science and bioinformatics made a huge difference, and I’d recommend them to any researcher tackling complex data analysis.”

John Shovelton - Head of Software Development - OGT

“We brought in an AWS Health Check shortly after migrating from an on-premises solution to the cloud. Our internal team had limited AWS experience and was largely relying on third-party recommendations. The goal was to sense-check our setup, get ahead of any cost or security pitfalls, and make sure we were on the right track as we scale.

The whole process was smooth and low-effort. After a short scoping call, we had a half-day session with Mark, who immediately stood out for his technical depth and personable, no-nonsense approach. He was able to quickly understand our setup, give us practical advice, and communicate it in a way that was easy to absorb and act on.

The Health Check gave us a clear view of where we could optimise for cost—things like reserved instances—and where we needed to tighten up our security. It also helped us start thinking ahead. Mark’s recommendations around account structure and scaling made us realise we’ll need to adapt our setup as we grow, and possibly rethink some aspects of the software architecture.

It came at the perfect time: just far enough post-migration to have real context, but early enough to avoid costly missteps down the line. We haven’t implemented everything yet, but we’ve got a clear roadmap and know where to focus. The insights were well worth the investment.”

Adam Bryant - CEO - CanSense

Prismea have enabled us to strengthen our plans, focus our technical efforts, refine our hiring schedule [...] in a way that supports our key business goals.

CSO - Covid testing company

“The policies and procedures that Prismea created for us not only met our needs for software development under ISO15189, but also seamlessly linked into our existing Azure DevOps processes and QA systems.”

Director - Clinical diagnostic company

“Prismea have provided a complete, joined up service: from bioinformatic analyses, to AWS cloud infrastructure as well as creating easy to implement PHI policies.

Prismea's professionalism and kindness in transferring knowledge to incoming scientists has made working with them incredibly easy and has helped us to grow our capabilities and team.

Product manager - Start-up biotech company

“I highly recommend biotechs aiming to grow quickly to speak with Mark and team.”